Cowan Elvia's Form 4 filing
Vaxcyte, Inc. (PCVX) · filed Dec 29, 2025
- Accession no.
- 0001960048-25-000010
- Filed
- Dec 29, 2025
- Trade date
- Dec 23, 2025
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $557.0K. It was filed 6 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cowan ElviaCIK 0001960048 | Officer (SVP, FINANCE) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Common Stock | SSaleDisposed | −4,907 | $47.90 | −$235,045.3 | 21,250 | Direct | |
| Dec 23, 2025 | Common Stock | SSaleDisposed | −6,716 | $47.94 | −$321,965.04 | 14,534 | Direct | |
| Dec 23, 2025 | Common Stock | GGiftDisposed | −1,000 | $0.00 | $0 | 13,534 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.